Recurrent Mantle Cell Lymphoma Completed Phase 1 Trials for Cilengitide (DB11890)

Also known as: Mantle Cell Lymphoma Recurrent

IndicationStatusPhase
DBCOND0028615 (Recurrent Mantle Cell Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00077155Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or LymphomaTreatment